Vanguard Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388M | Sell |
|
|||||
|
2025
Q1 | $509M | Sell |
|
|||||
|
2024
Q4 | $451M | Buy |
|
|||||
|
2024
Q3 | $519M | Sell |
|
|||||
|
2024
Q2 | $527M | Buy |
|
|||||
|
2024
Q1 | $433M | Sell |
|
|||||
|
2023
Q4 | $302M | Buy |
|
|||||
|
2023
Q3 | $278M | Buy |
|
|||||
|
2023
Q2 | $200M | Buy |
|
|||||
|
2023
Q1 | $96.3M | Buy |
|
|||||
|
2022
Q4 | $94.1M | Buy |
|
|||||
|
2022
Q3 | $76.4M | Buy |
|
|||||
|
2022
Q2 | $70.2M | Buy |
|
|||||
|
2022
Q1 | $70M | Buy |
|
|||||
|
2021
Q4 | $71.6M | Buy |
|
|||||
|
2021
Q3 | $46.4M | Buy |
|
|||||
|
2021
Q2 | $57.6M | Buy |
|
|||||
|
2021
Q1 | $64M | Buy |
|
|||||
|
2020
Q4 | $44.3M | Buy |
|
|||||
|
2020
Q3 | $31.6M | Buy |
|
|||||
|
2020
Q2 | $30M | Buy |
|
|||||
|
2020
Q1 | $27.6M | Buy |
|
|||||
|
2019
Q4 | $34M | Buy |
|
|||||
|
2019
Q3 | $20.7M | Buy |
|
|||||
|
2019
Q2 | $20M | Buy |
|
|||||
|
2019
Q1 | $11.6M | Buy |
|
|||||
|
2018
Q4 | $7M | Buy |
|
|||||
|
2018
Q3 | $3.05M | Buy |
|
|||||
|
2018
Q2 | $2.28M | Buy |
|
|||||
|
2018
Q1 | $1.5M | Buy |
|
|||||
|
2017
Q4 | $779K | Buy |
|